
WIHW-LP - Wikipedia
WIHW-LP (96.1 FM) is a radio station licensed to serve Dover, Delaware. The station is owned by Capitol Baptist Church. It airs a Christian radio format featuring programming from the Fundamental Broadcasting Network. [2]
Novel Drug Can Reduce Lipoprotein (a) by More Than 80%
2024年11月18日 · The findings suggest that the therapy could be a promising treatment to help prevent premature heart disease in people with high levels of Lp(a), which is estimated to affect 64 million people in the United States and 1.4 billion people worldwide. As many as 20%-25% of the world’s population has elevated Lp(a), according to estimates.
Lipoprotein (a) | American Heart Association
Often referred to as Lp (a), lipoprotein (a) is a type of lipoprotein that is genetically inherited and in high levels is a common independent risk factor for heart disease. How common is high Lp (a)? Should I know my Lp (a) number? Family or personal history of heart disease or premature cardiovascular disease.
Lipoprotein (a) Meaning and How Does it Impact My Heart Health?
2023年11月29日 · Lp (a) is a genetically inherited lipoprotein and a common independent risk factor for heart disease. Lp (a) is made up of two major proteins: apolipoprotein (a) [apo (a)] and apolipoprotein B (apoB)-100.
The latest on lipoprotein (a), an inherited cause of early heart ...
2023年2月1日 · About 20% of people have high blood levels of lipoprotein(a)—Lp(a) for short—which can double or triple their risk of a heart attack. With new treatments that can lower Lp(a) on the horizon, cardiologists are now testing more people for this biomarker.
New Drugs Offer Hope for People With High Lipoprotein(a
2025年1月21日 · All five new drug candidates have been shown to be safe in small early studies and to effectively lower Lp (a) levels. But what the FDA will ultimately look at is whether those results hold among...
An Update on Lipoprotein(a): The Latest on Testing, Treatment, …
2023年9月19日 · New lines of therapy targeting lipoprotein (a) (LPA) gene translation are being developed. Lipoprotein (a) (Lp [a]) is a low-density lipoprotein–like molecule with an apolipoprotein (b) moiety that is covalently attached to apolipoprotein (a) (Apo [a]), a plasminogen-like protein that confers several pathologic features to Lp (a).
Lilly's muvalaplin lowered lipoprotein(a) levels in adults with high ...
2024年11月18日 · Muvalaplin, an oral, once-daily treatment that inhibits lipoprotein (a) formation via a novel mechanism, achieved positive results in a 12-week Phase 2 study. These data were published in the Journal of the American Medical Association (JAMA) and simultaneously presented today at the American Heart Association (AHA) Scientific Sessions 2024.
Lipoprotein(a) - Prevention and Treatment of Atherosclerosis
2021年7月2日 · Lipoprotein(a) [Lp(a)] is an atherogenic lipoprotein with a strong genetic regulation. Up to 90% of the concentrations are explained by a single gene, the LPA gene. The concentrations show a several-hundred-fold interindividual variability ranging from less than 0.1 mg/dL to more than 300 mg/dL.
Lipoprotein(a) in the Year 2024: A Look Back and a Look Ahead
2024年6月26日 · There has been substantial progress in understanding the biology and pathophysiology of Lp (a) in the last 6 decades, including its discovery as a unique β-lipoprotein containing the pathognomonic apo (a) moiety covalently bound to apoB-100, its independent monogenetic association with cardiovascular disease (CVD) and calcific aortic valve disea...